CACan Acipayam

Can Acipayam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Can Acipayam has a total of 227 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Haemophilia Management in Natural Disasters—From Field to Consensus Report

    by Ahmet Muzaffer Demir, Selin Aytaç, Serap Karaman, Can Acıpayam, Muhlis Cem Ar, Bülent Antmen, Adalet Meral Güneş, Kaan Kavaklı, Hasan Kaya, Vahap Okan, et al.

    Objective: The earthquake in Türkiye had a profound impact on both haemophilia patients and healthcare services in the region. This experience highlighted the need for an effective action plan for patients with bleeding disorders in extraordinary situations. Methods: This is a cross‐sectional survey study designed to identify the needs of patients and physicians, as well as problems in health services. Two questionnaires were prepared and analysed. The first questionnaire consists of 26 questions for patients, including physical problems, difficulties in accessing doctors/treatment, and storage problems. A focus group including 15 questions has been conducted with physicians. Results: A total of 10 patients (diagnosed with severe haemophilia A and B) and 8 physicians participated in the study. Most of them reported bleeding due to impact, difficulties in accessing factors/health services, and some of them had to change cities. Factors could not be stored in appropriate conditions due to damage/power outages. The physicians who participated in the study were paediatric haematologists. Since the institutions where some of them worked were damaged, working conditions/patient follow‐up became difficult. Physicians had difficulty reaching their patients who had moved to other cities and assessing the level of factors in patients who applied. Conclusion: This research revealed that managing chronically ill patients during disasters requires special attention. Patients emphasized the importance of knowing their health status in times of crisis. This article serves as a resource for consensus reports that associations may prepare.

  • Open Access

    COVID-19 related mucormycosis and hemophagocytic lymphohistiocytosis in a child with juvenile myelomonocytic leukemia

    by Kübra Aslan, Hatice Beyza Akkan, Fırat Özçelik, Kerem Kökoğlu, Alper Özcan, Can Acıpayam, Ayşenur Paç Kısaarslan, Benhur Şirvan Çetin, Özlem Canöz, Munis Dündar, et al.

    Juvenile myelomonocytic leukemia (JMML) is a childhood hematological cancer that often results from mutations in the PTPN11 gene. This study aims to report an original proband with JMML, COVID-19, HLH, and mucormycosis phenotypes. In JMML patients, secondary HLH associated with SARS-CoV-2 and mucor infection has not been reported in the literature. We identified a missense variant c.226G>C (p. Glu76Gln) (NM_001330437) in PTPN11. The patient suffered from SARS-CoV-2-related secondary Hemophagocytic lymphohistiocytosis (HLH) and mucormycosis in the right eye and the synoidal ethmoidal sinuses, which eventually led to the patient’s death due to cardiopulmonary arrest. We report a child with JMML complicated with COVID-19-related secondary HLH and mucormycosis, which underlines the need for effective and urgent treatment to reduce further mortalities.

  • Open Access

    Effects of Type 1 diabetes mellitus disease on iron metabolism and hepcidin level abstract

    by Bekir Ay, Can Acıpayam, Nurten Seringeç Akkeçeci, Fatih Temiz, Fatma İnAnç Tolun

    Purpose: The aim of this study was to reveal the relationship between iron metabolism, hepcidin, and hemoglobin A1c (HbA1c) in type 1 diabetes mellitus (T1DM) patients with better and poor metabolic control. Materials and Methods: The study included 30 T1DM patients with poor metabolic control (HbA1c value >7.5%), 30 T1DM patients with better metabolic control (HbA1c value ≤7.5%), and 30 healthy controls who were of similar age and gender. Routine, hemogram, biochemical tests, iron, transferrin, and ferritin levels were evaluated. Results: The hepcidin level of the poor metabolic patient group (519.52±114.58) was significantly higher than the control group (431.94±124.05). The ferritin level of the poor metabolic patient group (52.10±36.53) was significantly higher than that of the better metabolic patient group (35.13±36.18) and the control group (28.63±18.08). Positive relationships were found between HbA1c and hepcidin and ferritin. In receiver operating characteristic (ROC) analysis, hepcidin was at the threshold value of 445.20 and had 61.7% sensitivity and 56.0% specificity in diagnosing T1DM. Conclusion: Hepcidin and ferritin levels have been shown to increase in T1DM patients and both show a positive correlation with HbA1c. Hepcidin may be a promising marker contributing to the follow-up and diagnosis of T1DM.

  • Open Access

    Anxiety and depression in adolescents with beta thalassaemia major

    by Defne Ay Tuncel, Sinem Yalnızoğlu Çaka, Sümeyra Topal, Can Acıpayam, Nisa Alkan, Seda Bozduman Çelebi

    Purpose: The course of Beta Thalassaemia Major triggers children's susceptibility to anxiety and depressive mood. The aim of this study was to determine the frequency of anxiety and depression in adolescents with Beta Thalassaemia Major and its relationship with hospitalisation. Materials and Methods: This correlational case-control study was conducted with a total of 77 healthy children (case=39, control=38) with a confirmed diagnosis of major thalassaemia. The data were collected using the "Descriptive Information Form", Revised Child Anxiety and Depression Scale - Child Version (RCADS-CV) and Hospital Anxiety and Depression (HAD) Scale. Results: When the comparison of the mean RCADS-CV scores according to the groups was analysed, it was found that the mean Major Depressive Disorder sub-dimension score was significantly higher in the case group. It was found that 61.5% of the children in the case group and 92.1% of the children in the control group experienced moderate depression and the difference was statistically significant. In addition, when the RCADS-CV cut-off score of 71 and above was evaluated, it was found that 12.8% of children with Beta Thalassaemia Major had a pathological picture. Conclusion: The high prevalence of major depressive disorders in children with Beta Thalassaemia Major and hospitalisation-related depression levels in healthy children is highly significant.

  • Open Access

    Evaluation of Complete Blood Count Parameters to Predict Abnormal Uterine Bleeding

    by Defne Ay Tuncel, Can Acıpayam

    Background/Objectives: To investigate the diagnostic value of hematological parameters in adolescents with abnormal uterine bleeding (AUB), to make early diagnoses, and to prevent life-threatening bleeding. Methods: A total of 141 children, 70 patients, and 71 controls were included in the study. The laboratory findings of the patient and control groups were obtained from medical records. Cut-off values were estimated using constructing receiver operating characteristic (ROC) curves of complete blood count parameters to differentiate patients with AUB from control patients. Results: WBC, neutrophil, eosinophil, neutrophil/lymphocyte ratio (NLR), systemic inflammatory response index (SIRI), CRP/albumin ratio, CRP, albumin, PDW, RDW, MPV, and APTT were higher in the AUB group compared to the control group (p = 0.010, p = 0.002, p = 0.017, p = 0.017, p = 0.005, p = 0.003, and p < 0.001, respectively). Erythrocytes, hemoglobin, hematocrit, MCV, MCH, MCHC, fibrinogen, and INR were lower in the AUB group than in the control group (p < 0.001 for all). According to ROC analysis, RDW showed the highest diagnostic performance, with an AUC of 0.999 (p < 0.001). PDW and MPV also demonstrated high diagnostic values (AUC = 0.995 and AUC = 0.928, respectively) (p < 0.001). The NLR, SIRI, and CRP/albumin ratio had moderate diagnostic efficacy, with AUC values of 0.612, 0.640, and 0.642 (p = 0.022, p = 0.004, and p = 0.004, respectively). Conclusions: The high diagnostic performance of parameters such as RDW, PDW, and MPV in diagnosing AUB indicates that these parameters should be considered in clinical applications.


  • Evaluation of endocrine changes and insulin release in patients with hereditary spherocytosis

    by Zeynep Ağırman, Fatih Temiz, Can Acıpayam, Nurten Akkececi

    Aim: To evaluate endocrinological changes and insulin secretion in patients with hereditary spherocytosis (HS).Methods: The study included 30 patients with HS and 30 healthy control groups who were of similar age and gender. Routine tests, including hemogram, biochemical and hormonal tests were conducted on both patients with HS and the control group. HOMA‐IR (Homeostasis Model Assessment for Insulin Resistance) and HOMA‐ß% (Homeostasis Model Assessment for ß‐cell function) values of all cases were also calculated using fasting insulin and fasting glucose values.Results: Among the patient group, 7 patients (23.3%) had short stature, 16 patients (53.3%) had vitamin D deficiency, 1 patient (3.3%) had impaired glucose tolerance, 1 patient (3.3%) had subclinical hypothyroidism, 23 patients (76.6%) had dyslipidemia and 2 patients (6.6%) had growth hormone deficiency. The insulin value in the patient group was 4.0 ± 2.7 mlU/mL and significantly lower than the control group with an insulin value of 9.1 ± 3.9 mlU/mL (P < 0.001). Moreover, glucose (P = 0.036), HOMA‐IR (P < 0.001), HOMA‐beta (P < 0.001) and C‐peptide (P = 0.001) values of the patient group were significantly lower than the control group. The cholesterol (P < 0.001), HDL (P < 0.001) and LDL (P < 0.001) values of the patient group were found to be significantly lower than the control group.Conclusion: We found that insulin secretion decreased in patients with HS and hypocholesterolemia occurred due to chronic hemolysis. More research is needed to elucidate the pathophysiology of decreased insulin secretion seen in HS patients.

  • Open Access

    Clinical spectrum of primary hemophagocytic lymphohistiocytosis: experience of reference centers in Central and Southeast Anatolia

    by Şefika Akyol, Ebru Yılmaz, Hüseyin Tokgöz, Kamuran Karaman, Esra Pekpak, Alper Özcan, Ayşe Şi̇mşek, Bilal Arslan, Ayşe Ceyda Ören, Habibe Selver Gökçeli̇, et al.

    Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease, with a high mortality if left untreated. In addition, the disease has unique diagnostic challenges. Therefore, despite the existing guidelines on management, current clinical practice data is informative on the course and outcome. Herein, a retrospective chart review study was conducted through the collaboration of six centers, located in central and southeastern Türkiye. The demographical data, laboratory results, and treatment outcomes were evaluated. Eighty-three patients were enrolled in the study. The mean age was 2 years, whereas the median age was 8 months with a range of a minimum of 1 week and a maximum of 12.6 years. Consanguineous marriage, history of sibling death, and familial history of similar disease were determined in 72.2% (n:60), 34.9% (n:29), and 39.8% (n:33) of the patients, respectively. The most common presentation was fever, followed by hepatosplenomegaly on admission. Disease-causing familial HLH variants were identified in 60.2% (n:50) of the patients. Hematopoietic stem cell transplantation (HSCT) was performed in 39.7% (n:33) of the cohort. The 2-year overall survival (OS) rate was 62.4% for the whole group. Comparing the patients who received HSCT and those who did not; the HSCT group had a 2-year OS of 84.7%, which was significantly better than patients who did not receive HSCT had a 2-year OS of 47.1% (p:0.001). Despite the improvement in HLH diagnostics and treatment options over the last decade, early death remains a leading problem for the survival of these patients. Therefore, appropriate assessment of the patients in experienced centers and HSCT are pivotal for better outcomes.


  • Soluble Receptor Level of Advanced Glycation (sRAGE) Products in Serum in Patients with Systemic Lupus Erythematosus:

    by Serdar Gök, Burak Okyar, Defne Ay Tuncel, Fatma İnanç Tolun, Filiz Alkan Baylan, Can Acıpayam, Adem Doğaner, Gözde Yıldırım Çetin

    Objectives: Systemic Lupus Erythematosus (SLE) is an autoimmune disease characterized by antibody formation against nuclear autoantigens. A receptor for Advanced Glycation (RAGE) is produced by many immune system cells, such as neutrophils, macrophages, and T cells, and interacts with many classes of ligands. In light of these results, the level of sRAGE, the soluble form of RAGE, may be associated with disease activity. In light of this information, we aimed to evaluate whether there is a relationship between plasma sRAGE levels and SLE. Materials and Methods: Eighteen patients diagnosed with SLE (M/F: 1/17) and twenty-one patients without any disease diagnosis (M/F: 2/19) were included as the control group. In these patients, plasma sRAGE level was measured by ELIZA method using an ELIZA (enzyme-linked immunosorbent assay) kit (BioVendor Research and Diagnostic Products). The data obtained were compared between the groups. Results: The mean plasma sRAGE level was lower in patients with SLE than in healthy control patients but not statistically significant (p=0.966). Our study found a positive correlation between SLEDAI and sRAGE levels in patients with SLE (r=0.628, p=0.005). Although no significant correlation was found between patients with SLE, sRAGE levels were positively correlated between fourteen patients classified as active SLE and the control group. Conclusions: In our study, we found that plasma sRAGE levels in patients with SLE were lower than in healthy controls, but plasma sRAGE levels in patients with active SLE were higher than plasma sRAGE levels in patients with inactive SLE. We hypothesized that reduced sRAGE levels in patients with SLE could be explained by the depletion of this soluble receptor. Our study differed from another similar study showing that blood sRAGE levels were higher in patients with SLE than in healthy controls. Blood sRAGE levels were significantly increased during active disease compared with patients with quiescent SLE.

  • Çoçukluk Çağı Kan ve Kan Ürünü Transfüzyonu Yapılan Hastaların Özellikleri, Transfüzyon Sıklığı, Eşik Değerleri ve Mortalite ile İlişkisi

    by Özge Özdemi̇r, Can Acipayam, Murat Aral, Sedef Terzi̇oğlu Öztürk

    Amaç: Bu çalışmanın amacı; kan ve kan ürünleri transfüzyonları yapılan hastaların değerlendirilmesi, transfüzyon endikasyonları, transfüzyon yapılan eşik değerler, transfüzyon sıklığı ve transfüzyon sıklığının mortalite üzerine ilişkisini belirlemektir. Gereç ve yöntemler: Çocuk Sağlığı ve Hastalıkları Anabilim Dalında 1 Ocak 2018-31 Aralık 2020 tarihleri arasında 28 gün-18 yaş arası kan ve kan ürünü transfüzyonu yapılan 419 hasta geriye dönük olarak incelendi. Bulgular: Çalışmaya dahil edilen hastaların 224 (% 53,5)’ünün erkek, 195 (% 46,5)’inin kız, yaş ortalaması 5,3±5,5 yıl ve transfüzyon sıklığı 4,3±9,2 defa olduğu saptanmıştır. Hastalardan 338’ine eritrosit süspansiyonu, 124’üne trombosit süspansiyonu, 110’nuna taze donmuş plazma transfüzyonu yapılmıştır. Transfüzyon yapılan hastalardan transfüzyon öncesi eşik değerler hemoglobin için 7,1 g/dL, trombosit için 24379/mm3, INR için 1,6 olarak saptandı. Hastaların 261 (% 62,3)’ine anemi, 96 (% 22,9)’sına trombositopeni nedeni ile transfüzyon yapılmıştır. Hastaların transfüzyon sıklığı ile mekanik ventilatörde kalma süresi (r=0,201, p= 0,042), yoğun bakım yatış süresi (r=0,375, p<0,001) ve ölüm günü (r=0,421, p= 0,002) karşılaştırıldığında aralarında pozitif ve anlamlı ilişki bulundu. Transfüzyon sıklığı ile eksitus olan ve olmayan hasta grupları karşılaştırıldığında, eksitus olanlara 9,0 (5,0-14,0) defa, eksitus olmayanlara ise 1,0 (1,0-2,0) defa transfüzyon yapıldığı tespit edildi. Sonuç: Transfüzyon yapılan hastalarda transfüzyon sıklığı ile mekanik ventilatörde kalma süresi, yoğun bakım yatış süresi ve mortalite oranı karşılaştırıldığında; sık transfüzyonun, hastalarda mekanik ventilatörde kalma ve yoğun bakımda yatış süresini uzattığı, mortalite için bir risk faktörü olduğu görülmüştür. Objective: The aim of this study; Evaluation of patients who received blood and, blood products transfusions, transfusion indications, transfusion threshold values, transfusion frequency, and the relationship between transfusion frequency and mortality. Material and methods: 419 patients between the ages of 28 days and 18 years, who underwent blood and blood product transfusion between January 1, 2018, and December 31, 2020, in the Department of Pediatrics, were retrospectively analyzed. Results: It was determined that 224 (53.5%) of the patients included in the study were male, 195 (46.5%) were female, the mean age was 5.3±5.5 years, and the frequency of transfusion was 4.3±9.2 times. Of the patients, 338 received erythrocyte suspension, 124 received thrombocyte suspension, and 110 had fresh frozen plasma transfusions. The pre-transfusion threshold values were found to be 7.1 g/dL for hemoglobin, 24379/mm3 for platelets, and 1.6 for INR. Transfusion was performed in 261 (62.3%) patients due to anemia and 96 (22.9%) due to thrombocytopenia. A positive and significant correlation was found between the frequency of transfusion and the duration of mechanical ventilation (r=0.201, p= 0.042), length of stay in the intensive care unit (r=0.375, p<0.001), and day of death (r=0.421, p= 0.002). When the transfusion frequency was compared with the deceased and non-exited patient groups, it was determined that 9.0 (5.0-14.0) times were transfused to those who died and 1.0 (1.0-2.0) to those who were not. Conclusion: When the frequency of transfusion, duration of stay on mechanical ventilator, length of stay in intensive care unit, and, mortality rate were compared in transfused patients; It has been observed that frequent transfusion is a risk factor for mortality, prolonging the duration of mechanical ventilator stay and, intensive care unit stay in patients.

  • 6 Ay-18 Yaş Suriyeli Mülteci Çocuklarda Anemi Etiyolojisi

    by Nurten Seri̇ngeç Akkeçeci̇, Can Acipayam, Ömer Duyuran

    Amaç: Bu çalışma Suriyeli mülteci çocuklarda anemi prevalansını ve etiyolojisini araştırmak amacıyla planlanmıştır. Gereç ve Yöntemler: Bu retrospektif çalışmaya, Ocak 2015-Eylül 2018 tarihleri arasında Kahramanmaraş Sütçü İmam Üniversitesi (KSÜ) Pediatrik Hematoloji ve Onkoloji polikliniğine başvuran, herhangi bir kronik hastalığı olmayan 6 ay-18 yaş arası 266 Suriyeli mülteci çocuk dahil edildi. Hastalar yaşlarına göre 6 ay-59 ay, 5-11 yaş, 12-14 yaş ve 15-18 yaş olmak üzere 4 gruba ayrıldı. Dünya sağlık örgütünün bu yaş gruplarında anemiyi tanımlamak ve sınıflandırmak için belirlediği hemoglobin konsantrasyonlarının yaşa özel cut-off değerleri kullanıldı. Bulgular: Çalışmaya dahil edilen 266 (89’u kız, 177’si erkek) Suriyeli mülteci çocuğun 111’inde (%41.7) anemi tespit edildi. 6 ay-59 ay yaş grubundaki çocukların 80’ninde (%54.4), 5-11 yaş grubundaki çocukların 22’sinde (%29.3), 12-14 grubundaki çocukların 6’sında (%24.0) ve 15-18 yaş grubundaki çocukların 3’ünde (%15.8) anemi tespit edildi (p